These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7773555)

  • 1. Encapsulated PC12 cell transplants into hemiparkinsonian monkeys: a behavioral, neuroanatomical, and neurochemical analysis.
    Kordower JH; Liu YT; Winn S; Emerich DF
    Cell Transplant; 1995; 4(2):155-71. PubMed ID: 7773555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymer-encapsulated PC-12 cells demonstrate high-affinity uptake of dopamine in vitro and 18F-Dopa uptake and metabolism after intracerebral implantation in nonhuman primates.
    Subramanian T; Emerich DF; Bakay RA; Hoffman JM; Goodman MM; Shoup TM; Miller GW; Levey AI; Hubert GW; Batchelor S; Winn SR; Saydoff JA; Watts RL
    Cell Transplant; 1997; 6(5):469-77. PubMed ID: 9331498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implantation of encapsulated catecholamine and GDNF-producing cells in rats with unilateral dopamine depletions and parkinsonian symptoms.
    Lindner MD; Winn SR; Baetge EE; Hammang JP; Gentile FT; Doherty E; McDermott PE; Frydel B; Ullman MD; Schallert T
    Exp Neurol; 1995 Mar; 132(1):62-76. PubMed ID: 7720827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of reaction of primate brain to grafted PC12 cells.
    Yoshida H; Date I; Shingo T; Fujiwara K; Miyoshi Y; Furuta T; Ohmoto T
    Cell Transplant; 1999; 8(4):427-30. PubMed ID: 10478724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overlesioned hemiparkinsonian non human primate model: correlation between clinical, neurochemical and histochemical changes.
    Oiwa Y; Eberling JL; Nagy D; Pivirotto P; Emborg ME; Bankiewicz KS
    Front Biosci; 2003 Sep; 8():a155-66. PubMed ID: 12957824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fetal nondopaminergic neural implants in parkinsonian primates. Histochemical and behavioral studies.
    Bankiewicz KS; Plunkett RJ; Jacobowitz DM; Kopin IJ; Oldfield EH
    J Neurosurg; 1991 Jan; 74(1):97-104. PubMed ID: 1670609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereotactic transplantation of a dopamine-producing capsule into the striatum for treatment of Parkinson disease: a preclinical primate study.
    Yoshida H; Date I; Shingo T; Fujiwara K; Kobayashi K; Miyoshi Y; Ohmoto T
    J Neurosurg; 2003 Apr; 98(4):874-81. PubMed ID: 12691415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sham surgery does not ameliorate MPTP-induced behavioral deficits in monkeys.
    Taylor JR; Elsworth JD; Sladek JR; Collier TJ; Roth RH; Redmond DE
    Cell Transplant; 1995; 4(1):13-26. PubMed ID: 7728327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional recovery in hemiparkinsonian primates transplanted with polymer-encapsulated PC12 cells.
    Aebischer P; Goddard M; Signore AP; Timpson RL
    Exp Neurol; 1994 Apr; 126(2):151-8. PubMed ID: 7925816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioral evaluation of hemiparkinsonian MPTP monkeys following dopamine pharmacological manipulation and adrenal co-graft transplantation.
    Howel LL; Byrd LD; McDonough AM; Iuvone PM; Bakay RA
    Cell Transplant; 2000; 9(5):609-22. PubMed ID: 11144958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restoration of dopamine transporter density in the striatum of fetal ventral mesencephalon-grafted, but not sham-grafted, MPTP-treated parkinsonian monkeys.
    Elsworth JD; Brittan MS; Taylor JR; Sladek JR; al-Tikriti MS; Zea-Ponce Y; Innis RB; Redmond DE; Roth RH
    Cell Transplant; 1996; 5(2):315-25. PubMed ID: 8689042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral nerve-dopamine neuron co-grafts in MPTP-treated monkeys: augmentation of tyrosine hydroxylase-positive fiber staining and dopamine content in host systems.
    Collier TJ; Elsworth JD; Taylor JR; Sladek JR; Roth RH; Redmond DE
    Neuroscience; 1994 Aug; 61(4):875-89. PubMed ID: 7838385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Striatal dopaminergic correlates of stable parkinsonism and degree of recovery in old-world primates one year after MPTP treatment.
    Elsworth JD; Taylor JR; Sladek JR; Collier TJ; Redmond DE; Roth RH
    Neuroscience; 2000; 95(2):399-408. PubMed ID: 10658619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of chronic levodopa treatment on pre- and postsynaptic markers of dopaminergic function in striatum of parkinsonian monkeys.
    Rioux L; Frohna PA; Joyce JN; Schneider JS
    Mov Disord; 1997 Mar; 12(2):148-58. PubMed ID: 9087972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modification of the number and phenotype of striatal dopaminergic cells by carotid body graft.
    San Sebastián W; Guillén J; Manrique M; Belzunegui S; Ciordia E; Izal-Azcárate A; Garrido-Gil P; Vázquez-Claverie M; Luquin MR
    Brain; 2007 May; 130(Pt 5):1306-16. PubMed ID: 17439984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preproenkephalin mRNA expression in the caudate-putamen of MPTP monkeys after chronic treatment with the D2 agonist U91356A in continuous or intermittent mode of administration: comparison with L-DOPA therapy.
    Morissette M; Goulet M; Soghomonian JJ; Blanchet PJ; Calon F; Bédard PJ; Di Paolo T
    Brain Res Mol Brain Res; 1997 Oct; 49(1-2):55-62. PubMed ID: 9387863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MRI detects acute degeneration of the nigrostriatal dopamine system after MPTP exposure in hemiparkinsonian monkeys.
    Miletich RS; Bankiewicz KS; Quarantelli M; Plunkett RJ; Frank J; Kopin IJ; Di Chiro G
    Ann Neurol; 1994 Jun; 35(6):689-97. PubMed ID: 8210225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal of hemiparkinsonian syndrome in nonhuman primates by amnion implantation into caudate nucleus.
    Bankiewicz KS; Palmatier M; Plunkett RJ; Cummins A; Oldfield EH
    J Neurosurg; 1994 Dec; 81(6):869-76. PubMed ID: 7965117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of locus coeruleus lesions on parkinsonian signs, striatal dopamine and substantia nigra cell loss after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in monkeys: a possible role for the locus coeruleus in the progression of Parkinson's disease.
    Mavridis M; Degryse AD; Lategan AJ; Marien MR; Colpaert FC
    Neuroscience; 1991; 41(2-3):507-23. PubMed ID: 1870701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Grafting of encapsulated dopamine-secreting cells in Parkinson's disease: long-term primate study.
    Date I; Shingo T; Yoshida H; Fujiwara K; Kobayashi K; Ohmoto T
    Cell Transplant; 2000; 9(5):705-9. PubMed ID: 11144970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.